ID

14276

Description

Dietary Supplementation With Soy Isoflavones in Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT00277446

Lien

https://clinicaltrials.gov/show/NCT00277446

Mots-clés

  1. 07/04/2016 07/04/2016 -
Détendeur de droits

CC BY-NC 3.0

Téléchargé le

7 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Asthma NCT00277446

Eligibility Asthma NCT00277446

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00277446
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
ages 18-50, males and females
Description

age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
physician diagnosis of asthma; requires daily asthma medication
Description

asthma

Type de données

boolean

Alias
UMLS CUI [1]
C0004096
moderate persistent disease (naepp guidelines)
Description

moderate persistent asthma

Type de données

boolean

Alias
UMLS CUI [1]
C1960047
fev1 65 to 90% of predicted
Description

fev1

Type de données

boolean

Alias
UMLS CUI [1]
C0748133
at least 12% increase in fev1 15-30 minutes after inhaling 2-4 puffs of albuterol or positive methacholine challenge (20% fall in fev1 at less than 8 mg/ml) - either of these can available from the previous 2 years
Description

fev1 albuterol or metacholine challenge

Type de données

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0001927
UMLS CUI [2,1]
C0430567
UMLS CUI [2,2]
C1446409
generally good health
Description

good health

Type de données

boolean

Alias
UMLS CUI [1,1]
C0018759
UMLS CUI [1,2]
C0205170
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
oral corticosteroid use within the past 3 months
Description

oral corticosteroid

Type de données

boolean

Alias
UMLS CUI [1,1]
C0149783
UMLS CUI [1,2]
C0040223
use of high dose inhaled corticosteroids (greater than 500 mcg of fluticasone per day or greater)
Description

inhaled corticosteroids

Type de données

boolean

Alias
UMLS CUI [1]
C2065041
current or former smoker (quit less than 6 months prior to study enrollment or greater than 10 pack years)
Description

smoking status

Type de données

boolean

Alias
UMLS CUI [1]
C1519386
UMLS CUI [2]
C1277691
recent asthma exacerbation (within 6 weeks)
Description

asthma exacerbation

Type de données

boolean

Alias
UMLS CUI [1]
C0349790
current consumption of soy isoflavone supplements
Description

soy isoflavone supplements

Type de données

boolean

known adverse reaction to genistein, other phytoestrogens, or soy products
Description

adverse reaction to genistein, other phytoestrogens, or soy products

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0061202
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0071011
UMLS CUI [3]
C2136331
pregnant
Description

pregnant

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
unintentional weight loss of more than 10 pounds within the year
Description

unintentional weight loss

Type de données

boolean

Alias
UMLS CUI [1]
C2363736
major or unstable medical condition
Description

comorbidity

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
use of an investigational drug in the previous 30 days
Description

use of an investigational drug

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0040223

Similar models

Eligibility Asthma NCT00277446

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00277446
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
ages 18-50, males and females
boolean
C0001779 (UMLS CUI [1])
asthma
Item
physician diagnosis of asthma; requires daily asthma medication
boolean
C0004096 (UMLS CUI [1])
moderate persistent asthma
Item
moderate persistent disease (naepp guidelines)
boolean
C1960047 (UMLS CUI [1])
fev1
Item
fev1 65 to 90% of predicted
boolean
C0748133 (UMLS CUI [1])
fev1 albuterol or metacholine challenge
Item
at least 12% increase in fev1 15-30 minutes after inhaling 2-4 puffs of albuterol or positive methacholine challenge (20% fall in fev1 at less than 8 mg/ml) - either of these can available from the previous 2 years
boolean
C0748133 (UMLS CUI [1,1])
C0001927 (UMLS CUI [1,2])
C0430567 (UMLS CUI [2,1])
C1446409 (UMLS CUI [2,2])
good health
Item
generally good health
boolean
C0018759 (UMLS CUI [1,1])
C0205170 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
oral corticosteroid
Item
oral corticosteroid use within the past 3 months
boolean
C0149783 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
inhaled corticosteroids
Item
use of high dose inhaled corticosteroids (greater than 500 mcg of fluticasone per day or greater)
boolean
C2065041 (UMLS CUI [1])
smoking status
Item
current or former smoker (quit less than 6 months prior to study enrollment or greater than 10 pack years)
boolean
C1519386 (UMLS CUI [1])
C1277691 (UMLS CUI [2])
asthma exacerbation
Item
recent asthma exacerbation (within 6 weeks)
boolean
C0349790 (UMLS CUI [1])
soy isoflavone supplements
Item
current consumption of soy isoflavone supplements
boolean
adverse reaction to genistein, other phytoestrogens, or soy products
Item
known adverse reaction to genistein, other phytoestrogens, or soy products
boolean
C0020517 (UMLS CUI [1,1])
C0061202 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0071011 (UMLS CUI [2,2])
C2136331 (UMLS CUI [3])
pregnant
Item
pregnant
boolean
C0032961 (UMLS CUI [1])
unintentional weight loss
Item
unintentional weight loss of more than 10 pounds within the year
boolean
C2363736 (UMLS CUI [1])
comorbidity
Item
major or unstable medical condition
boolean
C0009488 (UMLS CUI [1])
use of an investigational drug
Item
use of an investigational drug in the previous 30 days
boolean
C0013230 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial